Salvatore Emma Jr., CEO/President at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), bought 1,400 shares at $3.70 ($5K) on 2016-12-16, disclosed to the SEC on 2016-12-20.
Open-market purchase of $5k HRT by CEO/President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| HRT | BUY | 2015-06-16 | $7K | — | Filing → |
| HRT | SELL | 2014-08-20 | $94K | — | Filing → |